PRL-8-53

Category: nootropic

Pharmacological Mechanism

Old (1972) cognitive-enhancement research compound — partial AChE inhibition + dopamine modulation. One small human trial showed 200% memory recall improvement (Hansl 1978). No follow-up trials in 50 years; sold via research-chem channels.

Half-Life (t½)

PO: 3h

Dosing Guidelines

• PO: Typical 10mg (Range: 5 - 20 mg)

Target Organ Systems

• nervous